James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 67,417 shares at $16.11 ($1.1M) on 2022-07-19, disclosed to the SEC on 2022-07-20.
Open-market sale of $1.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.06 | 12,978 | $208K | 19.2% |
| 2 | $16.06 | 12,978 | $208K | 19.2% |
| 3 | $16.46 | 983 | $16K | 1.5% |
| 4 | $16.11 | 20,239 | $326K | 30.0% |
| 5 | $16.11 | 20,239 | $326K | 30.0% |
| Total | $16.10 avg | 67,417 |
| $1.1M |
| 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |